The Securities and Exchange<\/a> Commission<\/strong> has approved the TXXS<\/strong>, the first 2x leveraged ETF on the SUI<\/a> token<\/a><\/strong>, launched by 21Shares US and now trading on Nasdaq. This product offers amplified daily exposure to SUI price movements via derivative instruments. A characteristic that makes it primarily suited for experienced traders employing short-term strategies.<\/p>\n\n\n\n On the first day of listing, over 4,700 shares<\/strong> were traded, closing at $24.57<\/strong>. This initial volume demonstrates genuine appetite for this type of amplified exposure, despite the risks inherent to leveraged products. Most importantly, the SEC’s approval represents a strong signal that US regulators recognize the growing maturity of the Sui ecosystem and are willing to expand the range of financial products associated with it.<\/p>\n\n\n\n This regulatory validation arrives at a strategic moment.<\/strong> Sui has just been integrated into a Vanguard index, strengthening its visibility among traditional institutional investors. The arrival of TXXS complements this momentum by offering active traders a tool to capitalize on the token’s daily volatility.<\/p>\n\n\n\n Over the past 24 hours, SUI has nevertheless dropped 1.59%<\/strong> to settle at $1.54<\/strong>, while trading volume declined by 37%<\/strong> to $871 million<\/strong>. This temporary contraction hasn’t dampened institutional enthusiasm, as evidenced by Grayscale’s parallel move.<\/p>\n\n\n\n